Key result
Pulmonary percutaneous valve implantation with a 32 mm Myval transcatheter heart valve was successfully performed in a patient with a large native RVOT, with no complications during the hospital stay.
Why the study?
Creating a stable landing zone smaller than the largest available valve is crucial for PPVI success, limiting suitable candidates with large native RVOT.
Is pulmonary percutaneous valve implantation with a 32 mm Myval transcatheter heart valve feasible and safe in a patient with a large native RVOT after surgically corrected Tetralogy of Fallot?
Case Report (n=1)
Is pulmonary percutaneous valve implantation with a 32 mm Myval transcatheter heart valve feasible and safe in a patient with a large native RVOT after surgically corrected Tetralogy of Fallot?
Pulmonary percutaneous valve implantation using a 32 mm Myval transcatheter heart valve is feasible and safe in patients with a large native RVOT following surgically corrected Tetralogy of Fallot.
Answers are grounded in this paper and cite their sources.
Successful single-case implantation supports feasibility in large native RVOT; hypothesis-generating and requires prospective validation before broader use.
Pulmonary percutaneous valve implantation (PPVI) is feasible with satisfactory mid-term results in patients with native right ventricular outflow tract (RVOT) and has been increasingly used instead of surgically implantable pulmonary valves. Creating a stable landing zone with a diameter less than the largest commercially available valve (previously available 29 mm and currently available 32 mm) is crucial for technical success of the procedure, limiting the number of suitable candidates for PPVI. We report the case of PPVI with a 32 mm Myval transcatheter heart valve in a patient with a large native RVOT (pre-stented with AndraStent XXL mounted on a 35 × 60 mm valve balloon catheter) lesion who had Tetralogy of Fallot surgically corrected. The post-procedural outcomes of this case were satisfactory with no complications reported during the hospital stay.
No takes yet. Share an insight, caveat, or question.
Ogando et al. (2021) conducted a case report in Large native right ventricular outflow tract (RVOT) lesion after surgically corrected Tetralogy of Fallot (n=1). Pulmonary percutaneous valve implantation (PPVI) with a 32 mm Myval transcatheter heart valve was evaluated on Post-procedural outcomes and complications during hospital stay. Pulmonary percutaneous valve implantation with a 32 mm Myval transcatheter heart valve was successfully performed in a patient with a large native RVOT, with no complications during the hospital stay.
Synapse has enriched 10 related papers. Consider them for comparative context: